Français Néerlandais Japonais Chinois Allemand Espagnol Portugais

Major innovation in fight against pleural cancer

05 Apr 2016 | Health Nutrition, A region on the move

Lille hospital plays a key role in new treatment for pleural cancer.

Healthcare innovation in Northern France

For over 10 years, medicine had made no progress in treating cancer of the pleura, the membrane lining the lungs.

But now the Bio-MAPS program, launched by Dr. Gérard Zalcman in close cooperation with 70 French hospital groups, has shown that Bevacizumab is effective in treating pleural cancer, significantly reducing mortality risk in 23% of patients who were treated with it.

Dr. Arnaud Scherpereel, head of pulmonology and thoracic oncology at Lille University Hospital Center (CHRU) and coordinator of the Bevacizumab project, stresses that the treatment is equally effective in all patient sub-groups, including those with the worst prognosis factors.

As a result, this new treatment solution is becoming the first-line therapy for patients with pleural cancer.

Back to news

News

Toyota Onnaing: Four generations of Yaris

Everyone is talking about the fact that the Toyota plant at Onnaing near Valenciennes will produce the brand's all-new SUV, but it is also the home of the Yaris in Europe, from the car’s first generation to...

[THE AUTOMOTIVE INDUSTRY] 8 myths debunked: why it makes sense to invest in France

“French labour costs are too high.” “The French don't work enough.” “High taxes are a killer for companies based in France.” Discover in 8 key points what prevents you from taking advantage of France's...

All news